Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
Turbett Surgical has been recognized by MedTech Outlook Magazine as the exclusive recipient of “Top 10 Medtech Startups - 2023,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with Rob Turbett, Co-founder of Turbett Surgical & Mike Zimmer, CEO of Turbett Surgical.
Rob Turbett, Co-founder of Turbett Surgical & Mike Zimmer, CEO of Turbett Surgical
Driving Success for Clients![]()
Our Instrument Pod eliminates repetitive processes. This simplifies the workload for all parties involved, enhancing job performance and capability


Company
Turbett Surgical
Management
Rob Turbett, Co-founder of Turbett Surgical & Mike Zimmer, CEO of Turbett Surgical
Description
Turbett Surgical is a medical device manufacturing company that has ingeniously engineered a sterilization pod designed to optimize the preparation and delivery of surgical instruments to the sterile field. With this pod, many of the repetitive steps that are currently required can be eliminated.
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Mike Zimmer, the current CEO, will transition the role to Dubiel over the next three months, ensuring a seamless change in leadership. Zimmer will then return to his position as a member of the Turbett Board of Directors. Dubiel is transitioning from his current role as Chief Commercial Officer, bringing with him a wealth of experience in high-growth scaling of organizations and several successful exits.
Quote from Mike Zimmer, Outgoing CEO:
"Over the past 18 months, Turbett Surgical has experienced remarkable growth and improvement in our market share, quality, and financial performance. This progress is a testament to the dedication and hard work of our entire team. I am thrilled to announce Bill Dubiel as the new CEO. Bill's 30+ years of experience across multiple healthcare segments, including executive sales positions with Roche Diagnostics and Bayer Healthcare, and his leadership of startup businesses, make him the perfect choice to lead Turbett Surgical into its next phase of growth. His experience in high-growth scaling of organizations and several successful exits will be instrumental in driving Turbett Surgical's future success. I look forward to supporting Bill and the company in my continued role on the board."
Quote from Bill Dubiel, Incoming CEO:
"I am honored to take on the role of CEO at Turbett Surgical. I am excited to build on the solid foundation that Mike and the team have established. Over the past six months, I have had the pleasure of meeting with many of our customers and learning about the unique strengths of our business. Speaking with customers, working with our dedicated team, and collaborating with our distributor partners have been incredibly rewarding experiences. Together, we are laying a strong foundation for rapid growth and scaling our company."
Bill Dubiel's appointment marks another significant milestone for Turbett Surgical as the company accelerates its growth and continues its success in the healthcare industry.